TabsDetailsBasic DetailsDate: Monday, August 26, 2019Type: PresentationMedical Product: 13-valent pneumococcal vaccine (PCV13), PCV13Health Outcome(s): Kawasaki diseaseMaterials: 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Kawasaki DiseaseAdditional InformationInformationHost: 35th International Conference on Pharmacoepidemiology & Therapeutic Risk ManagementRelated Assessment(s): Abstracts of the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Pennsylvania Convention Center, Philadelphia, PA, USA, August 24‐28, 201913-Valent Pneumococcal Conjugate Vaccination (PCV13) and Kawasaki DiseaseContributorsPresenter(s): Meghan A. Baker, Bethany Baer, Martin Kulldorff, Lauren Zichittella, Rebecca Reindel, Sandra DeLuccia, Hana Lipowicz, Katherine Freitas, Robert Jin, Katherine Yih
